GlassScriptPhysician profile
Cole N Rojas
NPI 1306341979
$2,824.89
in general payments reported to CMS, 2019-2025
16 companies · $812 in 2025
The $812 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $413 · 2023: $935 · 2024: $522 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.12 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $850.52 | 2021-2025 | Clareon, Argos, Tryptyr |
| Rxsight INC | $636.18 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Glaukos Corporation | $321.73 | 2022-2025 | Istent Infinite, Idosetr, Idose |
| Astellas Pharma US INC | $158.44 | 2023-2025 | Izervay |
| New World Medical,INC. | $151.11 | 2023-2025 | Streamline, Clearpath, Ahmed Glaucoma Valve |
| Apellis Pharmaceuticals, INC. | $134.28 | 2023-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $89.50 | 2022-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $86.67 | 2022-2025 | Vabysmo |
| Sight Sciences, INC. | $82.55 | 2023-2024 | Omni Surgical System, Tearcare System |
| Ocular Therapeutix, INC. | $73.32 | 2024-2025 | Dextenza |
| Bausch & Lomb Americas INC. | $71.06 | 2023-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Rayner Intraocular Lenses Limited | $54.91 | 2023-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Carl Zeiss Meditec Cataract Technology INC. | $46.51 | 2023 | |
| Abbvie INC. | $23.36 | 2025 | |
| Harrow Eye, LLC | $23.00 | 2024 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $21.75 | 2025 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.